HIGHLIGHTS
- who: Yaqi Wang and collaborators from the Tongji University School of Medicine, China have published the research: Neoadjuvant chemoradiotherapy combined with immunotherapy for locally advanced rectal cancer: A new era for anal preservation, in the Journal: (JOURNAL)
- what: Except for 4 patients who were excluded from the analysis for various reasons, 15 of the remaining 40 patients achieved pCR (37.5%), and 12 patients achieved near-pCR (TRG 1, 30%). Neoadjuvant therapy for LARC has been transformed from the traditional era with the main purpose of controlling local recurrence to the new era with the . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.